GB9907055D0 - Antibacterial agents - Google Patents

Antibacterial agents

Info

Publication number
GB9907055D0
GB9907055D0 GBGB9907055.9A GB9907055A GB9907055D0 GB 9907055 D0 GB9907055 D0 GB 9907055D0 GB 9907055 A GB9907055 A GB 9907055A GB 9907055 D0 GB9907055 D0 GB 9907055D0
Authority
GB
United Kingdom
Prior art keywords
antibacterial agents
atoms
fused
optionally substituted
heterocyclic ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9907055.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Priority to GBGB9907055.9A priority Critical patent/GB9907055D0/en
Publication of GB9907055D0 publication Critical patent/GB9907055D0/en
Priority to PCT/GB2000/001175 priority patent/WO2000058294A1/en
Priority to EP00914262A priority patent/EP1165532B1/en
Priority to AU35657/00A priority patent/AU3565700A/en
Priority to AT00914262T priority patent/ATE286887T1/de
Priority to JP2000607997A priority patent/JP2002540197A/ja
Priority to ES00914262T priority patent/ES2235844T3/es
Priority to DE60017374T priority patent/DE60017374T2/de
Priority to US09/914,049 priority patent/US6503897B1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GBGB9907055.9A 1999-03-29 1999-03-29 Antibacterial agents Ceased GB9907055D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB9907055.9A GB9907055D0 (en) 1999-03-29 1999-03-29 Antibacterial agents
PCT/GB2000/001175 WO2000058294A1 (en) 1999-03-29 2000-03-28 Antibacterial agents
EP00914262A EP1165532B1 (en) 1999-03-29 2000-03-28 Antibacterial agents
AU35657/00A AU3565700A (en) 1999-03-29 2000-03-28 Antibacterial agents
AT00914262T ATE286887T1 (de) 1999-03-29 2000-03-28 Antibakterielle mittel
JP2000607997A JP2002540197A (ja) 1999-03-29 2000-03-28 抗菌剤
ES00914262T ES2235844T3 (es) 1999-03-29 2000-03-28 Agentes antibacterianos.
DE60017374T DE60017374T2 (de) 1999-03-29 2000-03-28 Antibakterielle mittel
US09/914,049 US6503897B1 (en) 1999-03-29 2000-03-28 Antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9907055.9A GB9907055D0 (en) 1999-03-29 1999-03-29 Antibacterial agents

Publications (1)

Publication Number Publication Date
GB9907055D0 true GB9907055D0 (en) 1999-05-19

Family

ID=10850463

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9907055.9A Ceased GB9907055D0 (en) 1999-03-29 1999-03-29 Antibacterial agents

Country Status (9)

Country Link
US (1) US6503897B1 (https=)
EP (1) EP1165532B1 (https=)
JP (1) JP2002540197A (https=)
AT (1) ATE286887T1 (https=)
AU (1) AU3565700A (https=)
DE (1) DE60017374T2 (https=)
ES (1) ES2235844T3 (https=)
GB (1) GB9907055D0 (https=)
WO (1) WO2000058294A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018453A1 (ja) * 2002-08-23 2004-03-04 Dainippon Pharmaceutical Co., Ltd. プロリン誘導体
US7442793B2 (en) 2002-12-11 2008-10-28 Smithkline Beecham Corporation Peptide deformylase inhibitors
WO2005000835A1 (en) * 2003-06-26 2005-01-06 Novartis Ag Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines
KR100753796B1 (ko) * 2006-07-28 2007-08-31 주식회사 프로메디텍 데포르밀라제 저해제, 이의 제조방법, 및 이를 포함하는조성물
SG181983A1 (en) * 2009-12-28 2012-08-30 Ajinomoto Kk Lanthionine derivative
CN102452998B (zh) * 2010-10-20 2014-12-10 天津药物研究院 N-甲酰羟胺类化合物及其制备方法和用途
KR101462851B1 (ko) 2012-10-24 2014-11-18 일동제약주식회사 신규 펩티드 데포르밀라제 저해제 화합물 및 그 제조방법
US9889204B2 (en) * 2014-08-11 2018-02-13 The Regents Of The University Of California Polymeric antibiotics
CA3248935A1 (en) 2022-04-14 2023-10-19 W. L. Gore & Associates, Inc. CHEMICAL ENTITIES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2132851C1 (ru) * 1993-08-05 1999-07-10 Синтекс (Ю.Эс.Эй) Инк. Производные амидов, являющиеся ингибиторами матричных металлопротеаз, фармацевтическая композиция
US6013792A (en) 1993-08-05 2000-01-11 Syntex (U.S.A.), Inc. Matrix metalloprotease inhibitors
JP2000511882A (ja) 1996-04-12 2000-09-12 ブリストル―マイヤーズ・スクイブ・カンパニー Ａｃｅ阻害剤及び／またはｎｅｐ阻害剤として有用なｎ―ホルミルヒドロキシルアミン化合物
DK1052984T3 (da) * 1998-02-07 2004-09-20 Vernalis Oxford Ltd Antibakterielle midler
US6288063B1 (en) 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
ES2235844T3 (es) 2005-07-16
ATE286887T1 (de) 2005-01-15
AU3565700A (en) 2000-10-16
US6503897B1 (en) 2003-01-07
EP1165532A1 (en) 2002-01-02
WO2000058294A1 (en) 2000-10-05
EP1165532B1 (en) 2005-01-12
JP2002540197A (ja) 2002-11-26
DE60017374D1 (de) 2005-02-17
DE60017374T2 (de) 2005-12-01

Similar Documents

Publication Publication Date Title
AU1676200A (en) Polyhydroxylated heterocyclic derivatives as anti-coagulants
MXPA02011977A (es) Herbicidas de piridina sustituidas.
CO5031285A1 (es) Triarilimidazoles
DK1109812T3 (da) Pyrrolobenzodiazepiner
DE50005437D1 (en) Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
BR0311771A (pt) Derivados de nonano e azabiciclo-octano com atividade inibitória da ddp-iv
IL108731A (en) 6, N-DISUBSTITUTED-£1, 2, 4| TRIAZOLO-£1, 5-a| PYRIMIDINE- 7-AMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS FUNGICIDES
SE9702773D0 (sv) Novel compounds
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
PL341239A1 (en) Dihydrobenzofuranes
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
IL150329A0 (en) 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
GB9907055D0 (en) Antibacterial agents
DE60008400D1 (de) Triazolopyrimidinderivate
BR0115996A (pt) Sulfamidotienopirimidinas
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
TR200100475T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
BR9912839A (pt) Derivados de piperazinomas e suas aplicações
ES2166710A1 (es) Nuevos compuestos heterociclicos con actividad antiinflamatoria.
MY131110A (en) Ergoline derivatives
GB9911556D0 (en) Immunosuppressant tricyclic compounds
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)